Loading...
Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro.
Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3665796?pdf=render |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|